FDA recall D-1391-2020

Fresenius Kabi USA, LLC · Class III · drug

Product

Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10

Reason for recall

Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.

Distribution

Nationwide within the United States

Key facts

Status
Terminated
Initiation date
2020-07-13
Report date
2020-07-22
Termination date
2022-08-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Zurich, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1391-2020